NCT06523101View on ClinicalTrials.gov

A Study of PJ009 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions
Short Bowel Syndrome
Interventions
DRUG

PJ009

Six participants in each dose level will be randomized to receive a single dose and/or multiple doses of PJ009 in a double-blind fashion.

DRUG

Placebo

Two participants in each dose level will be randomized to receive placebo in a double-blind fashion.

Trial Locations (1)

030001

The Second Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Chongqing Peg-Bio Biopharm Co., Ltd.

INDUSTRY